Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Nov 13.
Published in final edited form as: Pediatr Res. 2016 Jul 18;80(5):719–728. doi: 10.1038/pr.2016.143

Alveolar Formation is Dysregulated by Restricted Nutrition but not Excess Sedation in Preterm Lambs Managed by Non-Invasive Support

Lisa A Joss-Moore 1,2,*, Synneva J Hagen-Lillevik 2, Calan Yost 1, Jennifer Jewell 1, Robert D Wilkinson 1, Sydney Bowen 1, Mar Janna Dahl 1, Li Dong 1, Zhengming Wang 1, Angela P Presson 1,3, Chong Zhang 3, Donald M Null 1,, Bradley A Yoder 1, Kurt H Albertine 1
PMCID: PMC5683895  NIHMSID: NIHMS918738  PMID: 27429203

Abstract

Background

Preterm birth and respiratory support with invasive mechanical ventilation frequently leads to bronchopulmonary dysplasia (BPD). A hallmark feature of BPD is alveolar simplification. For our preterm lamb model of BPD, invasive mechanical ventilation is associated with postnatal feeding intolerance (reduced nutrition) and sedation. In contrast, preterm lambs managed by non-invasive support (NIS) have normal alveolar formation, appropriate postnatal nutrition, and require little sedation. We used the latter, positive-outcome group to discriminate the contribution of reduced nutrition versus sedation on alveolar simplification. We hypothesized that, restricted nutrition, but not sedation, contributes to impaired indices of alveolar formation in preterm lambs managed by NIS.

Methods

Preterm lambs managed by NIS for 21d were randomized into three groups: NIS control, NIS plus restricted nutrition, and NIS plus excess sedation. We quantified morphological and biochemical indices of alveolar formation, as well as mesenchymal cell apoptosis and proliferation.

Results

Restricted nutrition impaired morphological and biochemical indices of alveolar formation, and reduced mesenchymal cell apoptosis and proliferation. Excess sedation did not alter these indices, although mesenchymal cell apoptosis was less.

Conclusions

Our results demonstrate that restricted nutrition, but not excess sedation, contributes to impaired alveolar formation during the evolution of BPD in chronically ventilated preterm lambs.

INTRODUCTION

Preterm birth accompanied by respiratory support because of respiratory failure increases the risk for bronchopulmonary dysplasia (BPD; also called neonatal chronic lung disease) (13). Even with advances in respiratory support and neonatal intensive care of preterm human infants, BPD remains a significant pediatric problem, with ~15,000 new cases each year in the United States (4).

Development of BPD is multi-factorial. Contributing factors include invasive mechanical ventilation with oxygen-rich gas (1, 2, 57). Prolonged invasive mechanical ventilation with oxygen-rich gas contributes to the development of BPD by disrupting the developmental processes of alveolar formation and capillary growth, leading to the histopathological characteristic of alveolar simplification (8, 9). For the focus of this study, inadequate postnatal nutrition and poor growth are also associated with the evolution of BPD (1012). Inadequate postnatal nutrition and poor growth of preterm infants occurs secondary to enteral feeding intolerance, clinically indicated fluid restriction, and micro/macro-nutrient deficiencies (2, 3, 11, 13). Inadequate nutrition and poor growth are associated with impaired alveolar formation (14, 15).

A secondary factor contributing to inadequate postnatal nutrition and impaired alveolar formation may be sedation. Sedation is commonly used during invasive mechanical ventilation to minimize discomfort and stress (16, 17). Postnatal sedation may reduce postnatal nutrition and growth via effects on gastrointestinal motility, absorption, and blood flow (1821). In the developing lung, sedation may also directly affect alveolar formation by disruption of lung cell-signaling pathways (2224).

Isolating the contribution of inadequate postnatal nutrition from the contribution of postnatal sedation on alveolar formation in chronically ventilated preterm infants is challenging. Our preterm lamb model of evolving BPD provides an opportunity to distinguish between the effect of inadequate postnatal nutrition and postnatal sedation on alveolar formation, using a respiratory support mode that is associated with alveolar formation: non-invasive support (NIS) (9). For NIS, we used nasal pulsatile Flow Ventilation® because preterm lambs supported by this mode for 21d have normal respiratory gas exchange and normal alveolar formation (6, 7). NIS has the added positive benefit of postnatal feeding tolerance that leads to intake of larger volumes of ewe’s milk, and better postnatal growth (6, 7). None of these good outcomes happens when invasive mechanical ventilation is used. Another positive outcome when NIS is used is less sedation is necessary compared to invasive mechanical ventilation (6, 7). Therefore, use of NIS to support preterm lambs provides a unique opportunity to test the hypothesis that inadequate nutrition will have a greater effect on morphological and biochemical indices of alveolar formation than excess sedation.

Three groups of preterm lambs managed by NIS: NIS control, NIS plus restricted nutrition, and NIS plus excess sedation. The primary finding of our study is that restricted nutrition, but not excess sedation, impairs morphological, physiological, and biochemical indices of alveolar formation in chronically ventilated preterm lambs. Our results demonstrate that inadequate nutrition is independently detrimental to alveolar formation in chronically ventilated preterm lambs.

RESULTS

Preterm Lamb Characteristics

Preterm lambs were delivered at 131 ± 2d gestation. Preterm lambs were randomized to one of three groups: (a) NIS control group (n=5; 5 females), (b) NIS plus restricted nutrition (NIS+RN, n=4; 2 females and 2 males), and (c) NIS plus excess sedation (NIS+ES, n=4; 2 females and 2 males). Birth weights of lambs did not vary significantly across the three groups. Sample size was too small to assess sex-specific effects.

Targeted oxygenation and ventilation were PaO2 60–90 mmHg and PaCO2 45–60 mmHg, respectively. Respiratory support parameters are summarized in Table 1. FiO2, PIP and MAP are not different between the NIS control versus the NIS+RN and NIS+ES groups. During the third week of life, the preterm lambs’ activity precluded keeping the nasal tube in place so blow-by O2 was provided as needed to maintain O2 saturation between 88 and 92%. Flow of blow-by O2 was lower for the NIS control and NIS+ES groups compared to the NIS+RN Weight gain of the lambs and nutritional parameters were assessed on the final day of study, day of life (DOL) 20, and over two consecutive phases of the study, phase 1 and phase 2. For weight gain, phase 1 is DOL 5–12, and phase 2 is DOL 13–20. For weight gain, the first phase began on DOL 5 because preterm lamb weight decreased and then increased during postnatal DOL 1–4. For nutritional parameters, phase 1 is postnatal DOL 1–12, phase 2 is DOL 13–20.

Table 1.

Respiratory support parameters with interventions for preterm lambs supported by non-invasive support (NIS) for 21 days (mean±SD).

Parameter Day of Life NIS NIS+RN NIS+ES
FiO2a 1 0.40 ± 0.05 0.47 ± 0.13 0.41 ± 0.18
2–4 0.33 ± 0.15 0.33 ± 0.17 0.40 ± 0.22
6–8 0.30 ± 0.10 0.31 ± 0.11 0.30 ± 0.09
13–15 0.28 ± 0.03 0.35 ± 0.12 0.25 ± 0.06
19–21a -- -- --

Blow-by Flow of Oxygen (L/min) b 19–21 None 8 ± 2* 1 ± 1

Peak Inspiratory Pressure (cmH2O) a 1 16 ± 2 15 ± 3 16 ± 5
2–4 7 ± 2 7 ± 6 6 ± 4
6–8 5 ± 2 6 ± 7 3 ± 2
13–15 3 ± 1 2 ± 2 2 ± 1
19–21a -- -- --

Mean Airway Pressure (cmH2O) a 1 9 ± 2 8 ± 2 8 ± 2
2–4 5 ± 1 5 ± 4 2 ± 1
6–8 4 ± 1 4 ± 4 4 ± 2
13–15 2 ± 1 1 ± 1 2 ± 1
19–21a -- -- --
*

p ≤ 0.05 compared to NIS and NIS+ES

a

measured at the ventilator

b

No nasal tube

At the end of the study, at DOL20, weight gain was significantly less in the NIS+RN group than the NIS control group (Table 2). Consistent with decreased weight gain at DOL 20, NIS+RN lambs received fewer total calories, fluid, protein and fat than NIS control lambs. At DOL 20 NIS+ES lambs weight gain, total calories, fluid, protein and fat was not different from NIS control lambs (Table 2). During phase 1 of the study, there was no daily differences in NIS+RN lamb weight gain, calories, fluid, protein or fat compared to NIS control lambs. In phase 2 of the study, daily weight gain, calories, fluid, protein and fat for NIS+RN group was significantly less than NIS control lambs (Table 2). During phase 1 of the study there was no difference in daily weight gain between NIS+ES lambs and NIS control lambs. However, during phase 1 NIS+ES lambs had greater daily calories, fluid, fat and protein than NIS control lambs. In phase 2, daily weight gain was also not different between NIS+ES and NIS control lambs. However, in phase 2 daily calories, fluid, protein and fat was significantly less in NIS+ES lambs than NIS control lambs (Table 2).

Table 2.

Linear mixed model estimates and 95% confidence intervals for weight gain and nutrition parameters for preterm lambs managed by non-invasive support (NIS) for 21 days.

NIS (n=5) Difference from NIS
NIS+RN (n=4) NIS+ES (n=4)
Weight Gain at DOL20 (Kg) 1.46 (0.97~1.94) −1.24 (−1.97~−0.51)* 0.37 (−0.36~1.10)
 Daily Weight Gain (Kg) Phase 11 0.05 (0.01~0.08) ≤0.00 (−0.06~0.06) 0.03 (−0.03~0.09)
Phase 22 0.19 (0.15~0.23) −0.19 (−0.25~−0.13)* ≤0.00 (−0.06~0.06)
Total Calories on DOL20 (kcal/Kg) 283 (249~318) −211 (−262~−159)* −41 (−93~10)
 Daily Change in Calories (kcal/Kg) Phase 1 8 (6~11) 1 (−3~5) 7 (3~11)*
Phase 2 15 (11~ 20) −29 (−36~−23)* −15 (−21~−8)*
Total Fluid on DOL20 (mL/Kg) 283 (245~320) −136 (−193~−79)* −31 (−88 ~26)
 Daily Change in Fluid Intake (mL/Kg) Phase 1 4 (1~7) 1 (−4~5) 6 (1~10)*
Phase 2 6 (1~10) −18 (−25 ~−12)* −8 (−14~−1)*
Protein on DOL20 (g/Kg) 15.6 (13.7~17.6) −12.2 (−15.2~−9.3)* −2.1 (−5.1~0.8)
 Daily Change in Protein Intake (g/Kg) Phase 1 0.6 (0.5~0.8) 0.1 (−0.2~0.3) 0.4 (0.2~0.6)*
Phase 2 0.8 (0.6~1.1) −1.7 (−2.1~−1.3)* −0.8 (−1.2~−0.4)*
Fat on DOL20 (g/Kg) 18.3 (16.0~20.5) −14.0 (−17.5~−10.8)* −2.6 (−5.9~0.8)
 Daily Change in Fat Intake (g/Kg) Phase 1 0.7 (0.6~0.9) 0.1 (−0.2~0.4) 0.5 (0.2~0.7)*
Phase 2 1.0 (0.7~1.3) −2.0 (−2.4~−1.5)* −0.9 (−1.4~−0.5)*
1

Phase 1 is postnatal DOL 5–12 for weight gain, and DOL 1–12 for all other parameters

2

Phase 2 is postnatal DOL 13–20

*

Significantly different from NIS

DOL, day of life; NIS, non-invasive support; RN, restricted nutrition; ES, excess sedation

Effect of Restricted Nutrition on Lung Outcomes

Histologically, terminal respiratory units appear simplified in the NIS+RN group compared to the NIS control group (Figure 1). For the NIS+RN group, the lung parenchyma had thick airspace walls and few secondary septa. Secondary septa that were present were short and thick. These simplified features were different from the lung parenchyma for the NIS control group. That group’s lung parenchyma had thin airspace walls and many secondary septa that were long and thin. Morphometry and stereology substantiated these impressions (Figure 1). The quantitative histological results showed that structural indices of alveolar formation were significantly different between the NIS+RN and NIS control groups (Figure 1). The NIS+RN group had significantly lower radial alveolar count and volume density of alveolar secondary septa compared to the NIS control group. Conversely, the NIS+RN group had significantly thicker distal airspace walls compared to the NIS control group.

Figure 1.

Figure 1

Histologic appearance and morphometric quantification of lung structure in preterm lambs supported by NIS, with or without restricted nutrition (RN). Panels a and b: NIS control lung. Panels c and d: NIS+RN lung. TRU = terminal respiratory unit, DAS = distal airspace, A = alveolus. * identifies the enlarged region in panels b and d. Lung parenchyma of the NIS control group has thinner distal airspace walls (arrow), and more and thinner alveolar secondary septa (arrowhead) compared to corresponding NIS+RN group (panels a and c, the scale bar is 20 μm; panels b and d, the scare bar is 100 μm). Images are representative of the morphometric results shown in panel e, f, and g. Morphometric results are shown as mean ± SD for n=4/group. White fill indicates NIS control; black fill indicates NIS+RN. Radial alveolar count (panel e) and volume density of secondary septa (panel f) are significantly greater in the NIS control group compared to the NIS+RN group. Distal airspace wall thickness (panel g) is significantly less in the NIS control group compared to the NIS+RN group. *Different from the NIS control group by Mann-Whitney U test (p < 0.05).

For efficient respiratory gas exchange, the lung’s parenchyma must become thin. Thinning occurs through gradual increased apoptosis, and decreased proliferation, of mesenchymal cells in the walls of the distal airspaces (saccules) (6). Therefore, we quantified biochemical markers of apoptosis and proliferation, and localized both protein markers (Figure 2). Relative abundance of the pro-apoptotic protein, cleaved caspase-3, was significantly lower for the NIS+RN group compared to the NIS control group. PCNA protein abundance, a marker of cellular proliferation, also was significantly lower for the NIS+RN group compared to the NIS control group. Immunohistochemistry showed that fewer mesenchymal-cell nuclei were immunostained brown for cleaved caspase 3 protein and PCNA protein for the NIS+RN group compared to the NIS control group.

Figure 2.

Figure 2

Quantification of cleaved caspase-3 and PCNA protein abundance in preterm lambs supported by NIS, with or without restricted nutrition (RN). White fill indicates NIS control, black fill indicates NIS+RN. Results are shown as mean ± SD for n=4/group. Panel a: Cleaved caspase-3 protein abundance. Panel b: PCNA protein abundance. Cleaved caspase-3 and PCNA protein abundance are significantly lower in lungs of NIS+RN group compared to NIS control group (*different from the NIS group by Mann-Whitney U test, p< 0.05). Panels c and d: NIS immunohistochemistry of (c) cleaved caspase 3 and (d) PCNA. Panels e and f: NIS+RN immunohistochemistry of (e) cleaved caspase 3 and (f) PCNA. Immunohistochemistry shows that fewer mesenchymal-cell nuclei are immunostained brown for cleaved caspase 3 protein in NIS+RN and PCNA protein for the NIS+RN group compared to the NIS control group (scale bar is 100 μm). Insets are enlargements of the region identified by the arrow in each panel.

Effect of Excess Sedation on Lung Outcomes

Histologically, terminal respiratory units appeared similar between the NIS+ES and NIS control groups (Figure 3). This observation is supported quantitatively by morphometric and stereologic measurements, which showed that the three structural indices of alveolar formation were similar between NIS+ES and NIS control groups.

Figure 3.

Figure 3

Histologic appearance and morphometric quantification of lung structure in preterm lambs supported by NIS, with or without excess sedation (ES). Panels a and b: NIS control lung. Panels c and d: NIS+ES lung. TRU = terminal respiratory unit, DAS = distal airspace, A = alveolus. * identifies the enlarged region in panels b and d. Lung parenchyma of the NIS control group is similar to the corresponding NIS+ES group (panels a and c, the scale bar is 20 μm; panels b and d, the scale bar is 100 μm). Images are representative of the morphometric results shown in panels e, f, and g. Morphometric results are shown as mean ± SD. White fill indicates NIS control, hatched fill indicates NIS+ES. Radial alveolar count (panel e), volume density of secondary septa (panel f), and distal airspace wall thickness (panel g) is not different between NIS control group and NIS+ES group.

We also quantified protein abundance of cleaved caspase 3 and PCNA, and immunolocalized both protein markers, for the NIS+ES and NIS control groups (Figure 5). Relative abundance of cleaved caspase-3 protein was significantly lower for the NIS+ES group compared to the NIS control group. However, relative abundance of PCNA protein was not different between the NIS+ES and NIS control groups. Immunohistochemistry showed that fewer mesenchymal-cell nuclei were immunostained brown for cleaved caspase 3 protein. The immunostain pattern for PCNA protein was similar between the NIS+ES and NIS control groups (Figure 4).

Figure 4.

Figure 4

Quantification of cleaved caspase-3 and PCNA protein abundance in preterm lambs supported by NIS, with or without excess sedation (ES). White fill indicates NIS control, hatched fill indicates NIS+ES. Results are shown as mean ± SD for n=4/group. Panel a: Cleaved caspase-3 protein abundance. Panel b: PCNA protein abundance. Cleaved caspase-3 abundance is significantly lower in lungs of NIS+ES group compared to NIS control group (*different from the NIS group by Mann-Whitney U test, p < 0.05). Panels c and d: NIS immunohistochemistry of (c) cleaved caspase 3 and (d) PCNA. Panels e and f: NIS+ES immunohistochemistry of (e) cleaved caspase 3 and (f) PCNA. Immunohistochemistry showed that fewer mesenchymal-cell nuclei were immunostained brown for cleaved caspase 3 protein. The immunostain pattern for PCNA protein was similar (scale bar is 100 μm). Insets are enlargements of the region identified by the arrow in each panel.

DISCUSSION

Our study provides the new insight that restricted nutrition for 21d in preterm lambs managed by NIS has a greater effect on alveolar formation than excess sedation. Preterm lambs managed by NIS that received restricted nutrition have impaired morphological, physiological, and biochemical indices of alveolar formation, as well as reduced mesenchymal cell apoptosis and proliferation. Preterm lambs managed by NIS that received excess sedation have normal morphological, physiological, and biochemical indices of alveolar formation, although with less mesenchymal cell apoptosis. Therefore, our study demonstrates the importance of adequate nutrition compared to sedation for appropriate alveolar formation in chronically ventilated preterm lambs.

The novelty of our study is we used preterm lambs managed by NIS for 21 days to discriminate between the impacts of limited nutrition versus sedation. We focused on NIS-managed preterm lambs because they tolerate enteral feedings and grow, and they require little sedation. In addition, NIS-managed preterm lambs have acceptable respiratory gas exchange that requires less supplemental oxygen, lower peak inspiratory pressure, and lower mean airway pressure than are required to support preterm lambs by invasive mechanical ventilation (6, 7). NIS-managed preterm lambs have appropriate alveolar formation whereas preterm lambs supported by invasive mechanical ventilation have alveolar simplification (6, 7). Therefore, we used the good outcomes of NIS-managed preterm lambs as the context for asking if alveolar simplification occurs as a consequence of limiting enteral feedings (restricted nutrition, RN) or providing sedation (excess sedation, ES). Because we kept respiratory gas exchange within acceptable ranges for PaO2, PaCO2, pH, and O2 saturation for all three groups of NIS-managed preterm lambs, the principal independent variables for our study are restricted nutrition and excess sedation.

The restricted nutrition protocol that we used is based on enteral intake by historical preterm lambs supported by invasive mechanical ventilation for 21d (6, 7). Those lambs gradually developed feeding intolerance during the third week of life, indicated by residuals in their stomach and poor growth (7). Our restricted nutrition protocol provided the NIS+RN lambs with matched volumes (mL/Kg/d) of sheep colostrum and milk that were tolerated daily by the historical preterm lambs. We used linear mixed effects model analysis to compare NIS, NIS+RN, and NIS+ES groups, fitting separate lines to the first and second phases of life. This was the simplest model that best described the weight and nutrition data, and was made possible by the presence of 1 inflection point in the data between day of life 12 and 13. From an enteral feeding perspective, two observations are made. First, the NIS+RN lambs received similar volumes of sheep colostrum and milk to NIS control lambs during the first phase of life (days 1–12). Second, during the second phase of life (days 13–20), NIS+RN lambs received less daily volume of sheep milk, and therefore less daily total calories, than NIS control lambs. Consistent with reduced caloric intake, weight gain was less during phase 2 for the of NIS+RN lambs compared to the NIS control lambs. The decline in daily milk volume, total calories, and weight gain in NIS+RN lambs was accompanied by alveolar simplification compared to the NIS control group. The outcomes for the NIS+RN group highlight the importance of sustained adequate nutrition during the entire period of respiratory support (25).

Our findings add to a body of work that examines the link between postnatal nutrition, alveolar structural development and BPD. In adult mice, restricted nutrition leads to loss of alveoli, while restoration of nutrition leads to regeneration of alveoli (14, 26). Regeneration of alveoli was accompanied by rapid onset of gene expression, and increased cell replication and proliferation. In other rat studies, direct nutritional restriction in the pre- and postnatal periods, as well as uteroplacental insufficiency, result in impaired alveolar formation (15, 27). Our study confirms those findings, in a clinically relavant model,by showing that restricted nutrition in the immature lung of chronically ventilated preterm lambs leads to alveolar simplification that involves less apoptosis and proliferation of mesenchymal cells in the walls of distal airspaces. Our recent studies showed that balance between apoptosis and proliferation of mesenchymal cells is sensitive to the mode of respiratory support in chronically ventilated preterm lambs (6, 7). The balance is shifted in favor of apoptosis during NIS respiratory management, whereas the balance is shifted in favor of proliferation during invasive mechanical ventilation. Based on the results of the present study, we propose that restricted nutrition disrupts the balance, too, but differently, in that restricted nutrition leads to static turnover of mesenchymal cells in the walls of distal airspaces (Figure 2). Static turnover may contribute to the persistently thick walls of the distal airspaces (Figure 1). An implication of our results is that alveolar simplification in the lung of preterm infants supported by invasive mechanical ventilation may be the combined manifestation of invasive mechanical ventilation and inadequate nutrition due to feeding intolerance.

Despite aggressive nutritional management, optimal nutritional delivery to preterm infants can be difficult because of physiologic and management limitations (1, 2, 28). Consistent with difficulties in nutritional management of preterm infants, postnatal growth restriction also occurs in a significant number of preterm infants, and is frequently more severe with earlier preterm birth or greater disease severity (2831). To facilitate adequate nutrition to preterm infants, parenteral nutrition is frequently used during early days of life, transitioning to enteral feeds as tolerated. Despite the advantage of parental nutrition for early growth and neurodevelopment (10), the amount of enteral nutrition appears to influence the development of BPD. For example, among preterm infants receiving combined enteral and parenteral nutrition, infants who developed BPD received less enteral feeding than those who did not develop BPD, despite both groups receiving the same total fluid volume, calories, and grams of macronutrient (32). We did not use parenteral nutrition because our goal was to assess the effect of enteral nutrition on alveolar formation. Although the three NIS groups did not receive parenteral nutrition, their total enteral intake and calories were equivalent during the first phase of life. Separation occurred during the second phase of life, when the NIS+RN group gradually developed severe total calorie and macronutrient restriction. Whether that consequence is avoidable by parenteral nutrition during that critical period of early postnatal development remains to be determined.

Sedation of preterm infants receiving invasive mechanical ventilation may affect alveolar formation directly, by altering lung cell-signaling, or indirectly by prolonging mechanical ventilation, or disrupting nutritional intake and/or absorption (18, 19, 22, 23, 33). In our study, preterm lambs in the NIS+ES group tolerated sheep colostrum and milk. During phase 1 of life, NIS+ES lambs consumed more milk than the NIS control group, for reasons that are not clear. However, the NIS+ES lambs gained the same amount of weight as the NIS control group during phase 1 and phase 2 of life. Increased milk intake and sustained weight gain suggest that gastrointestinal function was not impaired by the dosage of pentobarbital given to the NIS+ES group. Because alveolar formation occurred in the NIS+ES lambs to the same extent as the NIS control lambs, we conclude that sedation, as we applied it, does not lead to alveolar simplification.

A limitation of our study is that parenteral nutrition was not provided (25). New studies are examining the impact of isocaloric nutrition provided enterally and parenterally. A limitation for translation may be use of pentobarbital in our studies. We use pentobarbital because it provides stable, continuous sedation of the lambs for these long, difficult studies. However, pentobarbital is rarely used for preterm infants, and thus the lack of effect on alveolar formation in preterm lambs may not be generalizable to sedatives that are used for preterm infants. For further clarification, the dosage of pentobarbital given to preterm lambs in the NIS+ES group was at the low-end of the dose range used to sedate the historical lambs that were supported by IMV. We used the low-end of the dosage range to avoid interfering with effective spontaneous breathing by the NIS+ES group of lambs. We suggest that the dosage of sedation given to the NIS+ES group of preterm lambs did not contribute to impaired alveolar formation in preterm lambs, lending further support to the major finding of our study, which is that reduced nutrition decreases alveolar formation. Sample size for this study is 4 to 5 preterm lambs/group. This sample size reflects balance between sample size requirements for statistical tests versus animal welfare expectations to use the minimum number of lambs. Consequently, sample size for our preterm lamb studies is small compared to studies of human preterm neonates. The small sample size may make type II statistical error a possibility. However, our cumulative experience is that when sample size is at least 4 and the data a normally distributed, statistical significance is reached at sample size of 4 (6, 7).Molecular mechanisms by which restricted nutrition may alter lung growth and alveolar formation remain to be identified. One potential mechanism of altered alveolar formation in NIS+RN lambs is oxidant injury. Several studies in rats demonstrate an additive effect of undernutrition and hyperoxic lung injury (34). Another potential mechanism may involve specific bioactive nutrients important in alveolar formation and the development of BPD (3). Of particular interest to our group are essential fatty acids. Preterm infants who develop BPD have alterations in circulating essential fatty acid profiles, including decreased docoshexanoic acid (DHA) (35). Studies from our laboratory show that reduced DHA is associated with impaired molecular signaling and alveolar formation in the lung of intrauterine growth restricted rat pups (36). Importantly, DHA supplementation restored molecular signaling and alveolar formation (36). We are assessing DHA levels in plasma and lung of chronically ventilated preterm lambs.

In conclusion, our study demonstrates that restricted nutrition, rather than excess sedation, reduces morphological, physiological, and biochemical indices of alveolar formation in chronically ventilated preterm lambs. Our results highlight the independent detrimental effect of inadequate nutrition on alveolar formation in chronically ventilated preterm lambs. Current studies are evaluating the contribution of overall calories, and the contribution of specific macronutrient activation of molecular signaling pathways that participate in alveolar formation.

METHODS

Surgical Preparation and Management of Preterm Lambs

The protocol for using chronically ventilated preterm lambs was in accordance with the American Physiological Society/US National Institutes of Health guidelines for humane use of animals for research. The protocol was prospectively approved by the Institutional Animal Care and Use Committee at the University of Utah, Health Sciences Center.

The methods for chronically ventilating preterm lambs are reported, including antenatal steroids and perinatal surfactant (6, 7, 37, 38). All lambs were initially intubated and supported by invasive MV for ~3h. Initial ventilator settings were: respiratory rate 60 breaths/min, inspiratory time 0.3s, PEEP 7 cmH2O, flow 8 L/min of 50% O2, and expiratory tidal volume 5–7 mL/Kg. Lambs were given an intravenous loading dose of caffeine citrate (15 mg/Kg, given over 2h, Mead Johnson & Company, Evansville, IN) to stimulate ventilatory drive within 30 min of delivery. Maintenance dose of caffeine citrate was 5 mg/Kg/d. Vascular pressures and heart rate were recorded continuously (model V6400; SurgiVet, Waukesha, WI). Intravenous dextrose was given to maintain plasma glucose between 60 and 90 mg/dL. Arterial partial pressure of oxygen (PaO2) was targeted between 70 and 90 mmHg by adjusting fractional inspired O2 (FiO2). Oxygenation saturation by pulse oximetry (SurgiVet, Smiths Medical, Dublin, OH) was targeted for 88–92%. Arterial partial pressure of carbon dioxide (PaCO2) was targeted between 40 and 60 mmHg, and pH between 7.25 and 7.45, by adjusting peak inspiratory pressure. Arterial blood gases, pH, electrolytes, glucose, and O2 saturation were measured hourly during the first days of life; less so thereafter to preserve blood volume, hematocrit, and total plasma protein.

All lambs were weaned to NIS, within ~3h of life, and were maintained on NIS for 21d (6, 7). Respiratory support was by pulsatile Flow Ventilation (model VDR4; Percussionaire, Sand Point, ID) through an uncuffed oral/nasal true Murphy tube (3.0 French; 13 cm length) that was inserted ~5 cm through a nostril (the nasal cavity is ~10cm in length in fetal lambs). Initial ventilator settings were background convective breaths at ~10 breaths/min, PIP of 20 to 25 cmH2O, PEEP of 5 to 7 cmH2O, and high-frequency rate at 8 to 10 Hz. Target ranges for PaO2 and PaCO2 were maintained by adjusting ventilator settings. Lambs were kept prone in a veterinary sling mounted on a radiantly heated bed. Lambs received daily antibiotics for 10d. Lambs also were given buprenorphine hydrochloride (5 mcg/Kg every 6h, Reckitt & Colman Pharmaceuticals, Richmond, VA).

Study Groups and Management of Preterm Lambs

To separate the effect of restricted nutrition versus excess sedation on morphological and biochemical indices of alveolar formation, we randomized NIS-supported preterm lambs to one of three study groups, all of which were supported for 21d. We took steps to minimize investigator bias during the conduct of this study. We prospectively randomized assignment to a study group before operative delivery of fetal lambs. Randomization was done by a person who did not participate in the delivery or resuscitation of the fetal lambs. Sample size was 4 to 5/group for compliance to reduce the number of lambs/group to that necessary to assess statistical differences (p<0.05). Sample size for the NIS control group was five because that was the number of control preterm lambs that accrued to reach n=4 each for the NIS+RN group and NIS+ES group. One group was supported by NIS with our standard nutritional regimen that leads to postnatal growth (NIS control), another group was supported by NIS with restricted nutrition (NIS+RN), and the third group was supported by NIS with our standard nutritional regimen and excess sedation (NIS+ES). We kept respiratory gas exchange within acceptable ranges for PaO2, PaCO2, and pH for all three groups of NIS-supported preterm lambs.

Initial feedings were via an orogastric tube. All lambs received sheep colostrum (Kid & Lamb Colostrum Replacement, Land O Lakes, Arden Hills, MN) for the first 3d of life. The initial volume (3 mL) was increased gradually by 3 to 5 mL increments, as tolerated, to attain a goal of 60 to 80 Kcal/Kg/d. At day of life 4, colostrum was replaced with mature sheep milk (Sav-A-Lam Milk Products, Chilton, WI). An orogastric tube was used until the lambs learned to suckle from a bottle (day of life 3 to 5). Milk volume was graduated as tolerated by the NIS and NIS+ES groups and lambs fed ad libitum for a target of 150 Kcal/Kg/d. For the NIS+RN group, milk restriction was based on the volume of milk (mL/Kg/d) tolerated by historical preterm lambs whose respiratory support was invasive mechanical ventilation for 21d (7, 37). Fluid homeostasis, as indicated by urine output (>1 to 2 mL/Kg/h) and mean arterial blood pressure (>45 mmHg) was maintained for all lambs by adjusting total fluid intake (colostrum, milk, saline, dextrose) based on output (withdrawn blood, urine, and stool). None of the lambs required treatment with pressors. Feeding and growth data were collected continuously over each 24h period. The studies ended on day of life 21 so daily calculations of intake and output are through day of life 20.

Lambs received pentobarbital (Abbott Laboratories, North Chicago, IL) at 1 to 2 mg/Kg, as needed (heart rate >200 beats/min). The NIS+ES group received pentobarbital dosage based on daily dosage (mg/Kg/d) needed to keep historical preterm lambs supported by invasive mechanical ventilation comfortable and calm (7, 37). A caveat is that we used pentobarbital dosages at the lower end of the daily range for the historical lambs to not interfere with spontaneous breathing.

Terminal Collection of Tissue

At necropsy, preterm lambs were given 60 mg/Kg pentobarbital sodium solution intravenously (Beuthanasia solution, Ovation Pharmaceuticals, Deerfield, IL). The lambs were intubated and reconnected to the Percussionaire ventilator to maintain lung inflation when the chest was opened to remove the lungs. Lung tissue preservation (frozen, fixed) was by methods that we reported (6, 7, 37, 38).

Quantification of Alveolar Secondary Septation and Distal Airspace Wall Thickness

We used morphometry and stereology to quantitatively compare alveolar secondary septation (radial alveolar count and secondary septal volume density) and distal airspace wall thickness, using methods previously reported by our group (7, 37). We used unbiased (systematic, uniform, random) sampling of the uniformly insufflated, whole left lung of each preterm lamb (39). Unbiased sampling involved cutting each left lung into uniformly thick slices, cutting each slice into uniform cubes, and using a random number generator to identify the first cube taken from the top left corner of each slice. Subsequent cubes were taken from every 10th cube across each slice to its bottom right corner (all done by one person). A random number generator was used to select two cubes per slice for embedding and sectioning (done by a second person), followed by image analysis (done by a third person). Image analysis of 10 blocks selected by this unbiased sampling method was sufficient to attain <15% coefficient of variation for radial alveolar count, volume density of secondary septa, and distal airspace wall thickness for each lung.

Immunoblotting

Immunoblotting of peripheral, whole-lung homogenate was used to quantify the relative abundance of Cleaved Caspase-3 (Enzo, Farmingdale, NY) and proliferating cell nuclear antigen (PCNA) (BioGenex, Fremont, CA) as previously described by our group (40).

Immunohistochemistry

We used standard methods to localize cleaved caspase 3 and PCNA in the lung, using the same antibodies that we used for immunoblot (37). Negative immunostaining controls were included (37).

Statistical Analysis

We used piecewise linear mixed effects regression models to compare the NIS+RN and NIS+ES groups to the NIS group. We modelled five outcomes: weight gain, total calories, total fluid, total protein, and total fat. For the weight gain outcome, the two phases of life were defined as postnatal DOL 5–12 and DOL 13–20. Choosing two phases provided a simple model that reflected the biphasic characteristics of the results for the NIS+RN group. The first phase for weight gain began on DOL 5 because preterm lamb weight was unstable during DOL 1–4, as expected. That is, preterm lamb weight decreased and then increased during postnatal DOL 1–4. For all other outcome variables, the phases were defined as postnatal DOL 1–12 and DOL 13–20. For each outcome, we fit a piecewise linear mixed effect model of the form:

eq.Outcome=Group+Phase1+Phase2+GroupPhase1+GroupPhase2+random(Lamp)

to account for correlations within the same lmb over time. For each model, we report group differences and 95% confidence intervals (CIs) in slopes for the first and second phases, and at the final time point (DOL 20).

Simple linear regression models were used to estimate average differences and 95% CIs for distal airspace wall (DASW) thickness and volume density of secondary septa (Vv sec septa) for the two comparisons: 1) NIS+RN vs. NIS and 2) NIS+ES vs. NIS. For western blot comparisons, we used non-parametric Mann Whitney U test.

Analyses used R v. 3.2.3 software. Statistical significance was assessed at the 0.05 level and all tests were two-tailed

Acknowledgments

Financial Support: This study was supported in part through a Primary Children’s Hospital Foundation Grant, Salt Lake City, Utah (LJM), National Institutes of Health (NIH), Bethesda, MD grants K01 DK084036 (LJM), R01-HL062875 (KHA), R01 HL110002 (KHA), and T35-HL07744 (KHA, Mentor), and the Division of Neonatology, Department of Pediatrics at the University of Utah

We thank the Division of Neonatology at the University of Utah for support.

Footnotes

Conflict: Authors have no conflicts of interest.

References

  • 1.Jobe AH. The new bronchopulmonary dysplasia. Curr Opin Pediatr. 2011;23:167–172. doi: 10.1097/MOP.0b013e3283423e6b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Schulzke SM, Pillow JJ. The management of evolving bronchopulmonary dysplasia. Paediatr Respir Rev. 2010;11:143–148. doi: 10.1016/j.prrv.2009.12.005. doi:110.1016/j.prrv.2009.1012.1005. Epub 2010 Jan 1025. [DOI] [PubMed] [Google Scholar]
  • 3.Akram Khan M, Kuzma-O’Reilly B, Brodsky NL, Bhandari V. Site-specific characteristics of infants developing bronchopulmonary dysplasia. J Perinatol. 2006;26:428–435. doi: 10.1038/sj.jp.7211538. Epub 2006 May 2018. [DOI] [PubMed] [Google Scholar]
  • 4.Bhandari V. Drug therapy trials for the prevention of bronchopulmonary dysplasia: current and future targets. Frontiers in pediatrics. 2014;2:76. doi: 10.3389/fped.2014.00076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Jobe AH. What is BPD in 2012 and what will BPD become? Early Hum Dev. 2012;88(Suppl 2):S27–28. doi: 10.1016/S0378-3782(12)70009-9. [DOI] [PubMed] [Google Scholar]
  • 6.Reyburn B, Li M, Metcalfe DB, et al. Nasal ventilation alters mesenchymal cell turnover and improves alveolarization in preterm lambs. Am J Respir Crit Care Med. 2008;178:407–418. doi: 10.1164/rccm.200802-359OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Null DM, Alvord J, Leavitt W, et al. High-frequency nasal ventilation for 21 d maintains gas exchange with lower respiratory pressures and promotes alveolarization in preterm lambs. Pediatr Res. 2014;75:507–516. doi: 10.1038/pr.2013.254. doi:510.1038/pr.2013.1254. Epub 2013 Dec 1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Coalson JJ. Pathology of bronchopulmonary dysplasia. Seminars in perinatology. 2006;30:179–184. doi: 10.1053/j.semperi.2006.05.004. [DOI] [PubMed] [Google Scholar]
  • 9.Albertine KH. Utility of large-animal models of BPD: chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol. 2015;308:L983–L1001. doi: 10.1152/ajplung.00178.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Stephens BE, Walden RV, Gargus RA, et al. First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants. Pediatrics. 2009;123:1337–1343. doi: 10.1542/peds.2008-0211. [DOI] [PubMed] [Google Scholar]
  • 11.Biniwale MA, Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:200–208. doi: 10.1053/j.semperi.2006.05.007. [DOI] [PubMed] [Google Scholar]
  • 12.Frank L, Sosenko IR. Undernutrition as a major contributing factor in the pathogenesis of bronchopulmonary dysplasia. Am Rev Respir Dis. 1988;138:725–729. doi: 10.1164/ajrccm/138.3.725. [DOI] [PubMed] [Google Scholar]
  • 13.Fanaro S. Feeding intolerance in the preterm infant. Early Hum Dev. 2013;89(Suppl 2):S13–20. doi: 10.1016/j.earlhumdev.2013.07.013. [DOI] [PubMed] [Google Scholar]
  • 14.Massaro D, Massaro GD, Baras A, Hoffman EP, Clerch LB. Calorie-related rapid onset of alveolar loss, regeneration, and changes in mouse lung gene expression. Am J Physiol Lung Cell Mol Physiol. 2004;286:L896–906. doi: 10.1152/ajplung.00333.2003. Epub 2003 Oct 2031. [DOI] [PubMed] [Google Scholar]
  • 15.Rehan VK, Sakurai R, Li Y, et al. Effects of maternal food restriction on offspring lung extracellular matrix deposition and long term pulmonary function in an experimental rat model. Pediatr Pulmonol. 2012;47:162–171. doi: 10.1002/ppul.21532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Marx CM, Smith PG, Lowrie LH, et al. Optimal sedation of mechanically ventilated pediatric critical care patients. Critical care medicine. 1994;22:163–170. doi: 10.1097/00003246-199401000-00029. [DOI] [PubMed] [Google Scholar]
  • 17.McPherson C. Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment? The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2012;17:351–364. doi: 10.5863/1551-6776-17.4.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Doherty TJ, Andrews FM, Provenza MK, Frazier DL. The effect of sedation on gastric emptying of a liquid marker in ponies. Veterinary surgery : VS. 1999;28:375–379. doi: 10.1111/j.1532-950x.1999.00375.x. [DOI] [PubMed] [Google Scholar]
  • 19.Lydon AM, Cooke T, Duggan F, Shorten GD. Delayed postoperative gastric emptying following intrathecal morphine and intrathecal bupivacaine. Canadian journal of anaesthesia = Journal canadien d’anesthesie. 1999;46:544–549. doi: 10.1007/BF03013544. [DOI] [PubMed] [Google Scholar]
  • 20.Colombato LA, Sabba C, Polio J, Groszmann RJ. Influence of anesthesia, postanesthetic state, and restraint on superior mesenteric arterial flow in normal rats. Am J Physiol. 1991;260:G1–6. doi: 10.1152/ajpgi.1991.260.1.G1. [DOI] [PubMed] [Google Scholar]
  • 21.Gumbleton M, Nicholls PJ, Taylor G. Differential influence of laboratory anaesthetic regimens upon renal and hepatosplanchnic haemodynamics in the rat. The Journal of pharmacy and pharmacology. 1990;42:693–697. doi: 10.1111/j.2042-7158.1990.tb06561.x. [DOI] [PubMed] [Google Scholar]
  • 22.Kim SH, Li M, Pyeon TH, So KY, Kwak SH. The volatile anesthetic sevoflurane attenuates ventilator-induced lung injury through inhibition of ERK1/2 and Akt signal transduction. Korean journal of anesthesiology. 2015;68:62–69. doi: 10.4097/kjae.2015.68.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Romero A, Moreno A, Garcia J, Sanchez C, Santos M, Garcia J. Effects of sevoflurane on ventilator induced lung injury in a healthy lung experimental model. Revista espanola de anestesiologia y reanimacion. 2016;63:22–28. doi: 10.1016/j.redar.2015.04.006. [DOI] [PubMed] [Google Scholar]
  • 24.Xiong XQ, Lin LN, Wang LR, Jin LD. Sevoflurane attenuates pulmonary inflammation and ventilator-induced lung injury by upregulation of HO-1 mRNA expression in mice. International journal of nanomedicine. 2013;6:1075–1081. doi: 10.2147/IJN.S41625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hay WW., Jr Strategies for feeding the preterm infant. Neonatology. 2008;94:245–254. doi: 10.1159/000151643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Massaro D, Alexander E, Reiland K, Hoffman EP, Massaro GD, Clerch LB. Rapid onset of gene expression in lung, supportive of formation of alveolar septa, induced by refeeding mice after calorie restriction. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1313–1326. doi: 10.1152/ajplung.00146.2006. Epub 2007 Jan 1319. [DOI] [PubMed] [Google Scholar]
  • 27.Joss-Moore L, Carroll T, Yang Y, et al. Intrauterine growth restriction transiently delays alveolar formation and disrupts retinoic acid receptor expression in the lung of female rat pups. Pediatr Res. 2013;73:612–620. doi: 10.1038/pr.2013.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ramel SE, Brown LD, Georgieff MK. The Impact of Neonatal Illness on Nutritional Requirements-One Size Does Not Fit All. Curr Pediatr Rep. 2014;2:248–254. doi: 10.1007/s40124-014-0059-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ehrenkranz RA, Das A, Wrage LA, et al. Early nutrition mediates the influence of severity of illness on extremely LBW infants. Pediatr Res. 2011;69:522–529. doi: 10.1203/PDR.0b013e318217f4f1. doi:510.1203/PDR.1200b1013e318217f318214f318211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ehrenkranz RA. Early, aggressive nutritional management for very low birth weight infants: what is the evidence? Semin Perinatol. 2007;31:48–55. doi: 10.1053/j.semperi.2007.02.001. [DOI] [PubMed] [Google Scholar]
  • 31.deRegnier RA, Guilbert TW, Mills MM, Georgieff MK. Growth failure and altered body composition are established by one month of age in infants with bronchopulmonary dysplasia. J Nutr. 1996;126:168–175. doi: 10.1093/jn/126.1.168. [DOI] [PubMed] [Google Scholar]
  • 32.Wemhoner A, Ortner D, Tschirch E, Strasak A, Rudiger M. Nutrition of preterm infants in relation to bronchopulmonary dysplasia. BMC Pulm Med. 2011;11:7. doi: 10.1186/1471-2466-11-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bhandari V, Bergqvist LL, Kronsberg SS, Barton BA, Anand KJ. Morphine administration and short-term pulmonary outcomes among ventilated preterm infants. Pediatrics. 2005;116:352–359. doi: 10.1542/peds.2004-2123. [DOI] [PubMed] [Google Scholar]
  • 34.Frank L, Groseclose E. Oxygen toxicity in newborn rats: the adverse effects of undernutrition. Journal of applied physiology: respiratory, environmental and exercise physiology. 1982;53:1248–1255. doi: 10.1152/jappl.1982.53.5.1248. [DOI] [PubMed] [Google Scholar]
  • 35.Martin CR, Dasilva DA, Cluette-Brown JE, et al. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr. 2011;159:743–749. e741–742. doi: 10.1016/j.jpeds.2011.04.039. doi:710.1016/j.jpeds.2011.1004.1039. Epub 2011 Jun 1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Joss-Moore LA, Wang Y, Baack ML, et al. IUGR decreases PPARgamma and SETD8 Expression in neonatal rat lung and these effects are ameliorated by maternal DHA supplementation. Early Hum Dev. 2010;86:785–791. doi: 10.1016/j.earlhumdev.2010.08.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Albertine KH, Dahl MJ, Gonzales LW, et al. Chronic lung disease in preterm lambs: effect of daily vitamin A treatment on alveolarization. Am J Physiol Lung Cell Mol Physiol. 2010;299:L59–72. doi: 10.1152/ajplung.00380.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Rehan VK, Torday JS. PPARgamma Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung. PPAR Res. 2012;2012:289867. doi: 10.1155/2012/289867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Hsia CC, Hyde DM, Ochs M, Weibel ER. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med. 2010;181:394–418. doi: 10.1164/rccm.200809-1522ST. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.MacRitchie AN, Albertine KH, Sun J, et al. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1011–1020. doi: 10.1152/ajplung.2001.281.4.L1011. [DOI] [PubMed] [Google Scholar]

RESOURCES